[SUNWAY] QoQ Cumulative Quarter Result on 30-Sep-2015 [#3]

Stock
[SUNWAY] SUNWAY BERHAD
Announcement Date
26-Nov-2015
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2015
Quarter
30-Sep-2015 [#3]
Profit Trend
QoQ- 34.68%
YoY- 20.35%
Quarter Report
Latest QR
Upcoming QR
SUNWAY's Result
SUNWAY's Financial Summary
View:
Show?
Cumulative Result
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Revenue 2,224,694 1,069,006 4,451,326 3,052,564 2,101,521 1,060,001 4,558,141 -38.03%
PBT 379,855 176,075 929,219 645,374 474,418 193,495 960,242 -46.14%
Tax -56,722 -32,842 -129,812 -100,632 -69,154 -36,077 -148,593 -47.40%
NP 323,133 143,233 799,407 544,742 405,264 157,418 811,649 -45.91%
-
NP to SH 256,463 102,101 732,433 517,757 384,448 146,540 734,011 -50.42%
-
Tax Rate 14.93% 18.65% 13.97% 15.59% 14.58% 18.64% 15.47% -
Total Cost 1,901,561 925,773 3,651,919 2,507,822 1,696,257 902,583 3,746,492 -36.39%
-
Net Worth 6,656,004 6,347,785 6,382,705 6,695,435 6,195,144 6,104,388 5,916,324 8.17%
Dividend
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Div 94,011 - 648,791 543,346 87,255 - 189,736 -37.41%
Div Payout % 36.66% - 88.58% 104.94% 22.70% - 25.85% -
Equity
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Net Worth 6,656,004 6,347,785 6,382,705 6,695,435 6,195,144 6,104,388 5,916,324 8.17%
NOSH 1,880,227 1,788,108 1,753,490 1,752,731 1,745,111 1,734,201 1,724,875 5.92%
Ratio Analysis
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
NP Margin 14.52% 13.40% 17.96% 17.85% 19.28% 14.85% 17.81% -
ROE 3.85% 1.61% 11.48% 7.73% 6.21% 2.40% 12.41% -
Per Share
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
RPS 118.32 59.78 253.86 174.16 120.42 61.12 264.26 -41.50%
EPS 13.64 5.71 41.77 29.54 22.03 8.45 42.55 -53.19%
DPS 5.00 0.00 37.00 31.00 5.00 0.00 11.00 -40.91%
NAPS 3.54 3.55 3.64 3.82 3.55 3.52 3.43 2.12%
Adjusted Per Share Value based on latest NOSH - 1,768,023
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
RPS 35.75 17.18 71.53 49.05 33.77 17.03 73.25 -38.03%
EPS 4.12 1.64 11.77 8.32 6.18 2.35 11.80 -50.44%
DPS 1.51 0.00 10.43 8.73 1.40 0.00 3.05 -37.44%
NAPS 1.0696 1.0201 1.0257 1.0759 0.9955 0.9809 0.9507 8.18%
Price Multiplier on Financial Quarter End Date
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Date 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 -
Price 3.00 3.14 3.08 3.15 3.44 3.65 3.29 -
P/RPS 2.54 5.25 1.21 1.81 2.86 5.97 1.24 61.36%
P/EPS 21.99 54.99 7.37 10.66 15.62 43.20 7.73 100.89%
EY 4.55 1.82 13.56 9.38 6.40 2.32 12.93 -50.18%
DY 1.67 0.00 12.01 9.84 1.45 0.00 3.34 -37.03%
P/NAPS 0.85 0.88 0.85 0.82 0.97 1.04 0.96 -7.79%
Price Multiplier on Announcement Date
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Date 29/08/16 27/05/16 26/02/16 26/11/15 27/08/15 26/05/15 25/02/15 -
Price 3.01 3.03 3.01 3.06 3.40 3.52 3.32 -
P/RPS 2.54 5.07 1.19 1.76 2.82 5.76 1.26 59.64%
P/EPS 22.07 53.06 7.21 10.36 15.43 41.66 7.80 100.17%
EY 4.53 1.88 13.88 9.65 6.48 2.40 12.82 -50.05%
DY 1.66 0.00 12.29 10.13 1.47 0.00 3.31 -36.90%
P/NAPS 0.85 0.85 0.83 0.80 0.96 1.00 0.97 -8.43%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment